TransCelerate accreditation

TransCelerate Accreditation

ICH GCP training (Good Clinical Practice E6 (R3)) performed by BioResearch, which is dedicated for our employees and external entities, was accredited by TransCelerate Biopharma Inc. and so we joined „GCP Mutual Recognition Program"

TransCelerate organisation aim is to unify GCP trainings for Research Teams and confirms that registered trainings fulfill basic program requirements.

GCP certificates which are issued after finishing the training are accepted by Sponsors and representatives of pharmaceuticals companies all over teh world.

BioResearch training was placed on the list of trainings of Transcelerate Biopharma Inc, which is presented at following link: http://www.transceleratebiopharmainc.com/gcp-training-attestation/training-providers/

What makes the training in BioResearch unique and valuable?

Practical approach supported by many years of experience of the Speakers, who as researchers carried out dozens of projects.

Aim

Preparation of researchers and research centers to perform delegated duties in accordance with GCP, local and international law.

To whom

To experienced and beginning researchers, research team: coordinators, pharmacists, lab technicians, nurses and other involved in the project.

Go back

News

Novel Nicotine Products Under Increasing Regulatory Pressure. Safety Studies Become a Key Pillar

Novel Nicotine Products Under Increasing Regulatory Pressure. Safety Studies Become a Key Pillar of Market Authorization

Read more …

Poland joins the global TOP 10 in clinical research

Poland joins the global TOP 10 in clinical research- — and we’re proud to be part of it

Read more …

Development towards modern risk assessment methods

We are starting a study in a population of patients with chronic obstructive pulmonary disease (COPD)

Read more …

Poland 2025: Hub for Life Sciences Innovation

Poland is rapidly becoming one of the most dynamic centers...

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲